Maheswaran, S., Doherty, K., Manoogian, A., Niemierko, A., Rieur, O., Hutchinson, J., Dedeoglu, A. S., Lloyd, M. R., Abelman, R., Spring, L., Isakoff, S. J., Moy, B., Wander, S. A., Vidula, N., Medford, A. J. (2026). Biomarker-driven prescribing patterns in
                    <i>ESR1</i>
                    <i>
                      <sup>mut</sup>
                    </i>
                    ER+/HER2- metastatic breast cancer (mBC).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.e23373